These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 35460073)

  • 21. The role of long noncoding RNAs in hepatocellular carcinoma.
    Huang Z; Zhou JK; Peng Y; He W; Huang C
    Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.
    Kansara S; Singh A; Badal AK; Rani R; Baligar P; Garg M; Pandey AK
    Semin Cancer Biol; 2023 Oct; 95():1-12. PubMed ID: 37364663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
    Lv H; Lv G; Han Q; Yang W; Wang H
    Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.
    Xu S; Wang L; Zhao Y; Mo T; Wang B; Lin J; Yang H
    J Biomed Sci; 2024 Feb; 31(1):25. PubMed ID: 38408962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
    Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
    J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
    Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma.
    Sheng J; Lv E; Xia L; Huang W
    Biomed Pharmacother; 2022 Sep; 153():113327. PubMed ID: 35779423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
    Falcon T; Freitas M; Mello AC; Coutinho L; Alvares-da-Silva MR; Matte U
    Biomed Res Int; 2018; 2018():2864120. PubMed ID: 30046591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming.
    Yang D; Sun L; Li Z; Gao P
    Adv Exp Med Biol; 2016; 927():191-215. PubMed ID: 27376736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB.
    Li Y; Ye Y; Chen H
    Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.